|||Page|| |---|---|---|---| |Report ofthe Trustees||1 to|5| |Report ofthe Independent
Auditors||6 to|8| |Statement of Financial Activities|||| |Balance Sheet||10 to|11| |Notes to the Financial Statements||12 to|19| |Detailed Statement of Financial|Activities|20 to|21| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Statement of Financial Activities|Statement of Financial Activities|||||| |---|---|---|---|---|---|---| |Incor
oratin
an income and|Ex enditure|Account||||| |for the Year Ended 30Se tember 2020||||||| ||||||30.9.20|30.9.19| ||||Unrestricted|Restricted|Total|Total| ||||fund|fund|funds|funds| |||Notes|E|E|E|E| |INCOME AND ENDOWMENTS
Donations
and legacies|FROM||7,529|11,355|18,884|22,125| |Charitable
activities
Research into and education|on oncology|||37,584|37,584|129,725| |Investment
income
Other income||2|8,064|32,124
1,400|40,188
1,400|46,056
500| |Total|||15,593|82,463|98,056|198,406| |EXPENDITURE ON
Raising funds||3|2,658|10,681|13,339|21,037| |Charitable
activities
Research into and education|on oncology||12,273|70,139|82,412|166,634| |Total|||14,931|80,820|95,751|187,671| |Net gains/(losses)
on investments|||(23,686)|(95,176)|(118,862)|17,208| |NET INCOME/(EXPENDITURE)|||(23,024)|(93,533)|(116,557)|27,943| |RECONCILIATION
OF FUNDS||||||| |Total funds brought forward|||302,461|1,215,400|1,517,861|1,489,918| |TOTAL FUNDS CARRIED FORWARD|||278427|1121867|14D1~D4|1817861| |The Mount Ver
~WT
t|non
Marie Curie Research|||||| |---|---|---|---|---|---|---| |Balance Sheet||||||| |~30 3
t
8|2I120|||||| ||||||30.9.20|30.9.19| ||||Unrestricted|Restncted|Total|Total| ||||fund|fund|funds|funds| |||Notes|f|f|f|f| |FIXED ASSETS
Investments||10|144,242|967,944|1,112,186|1,231,612| |CURRENT ASSETS
Debtors
Cash at bank||11|2,000
141,700|13,985
142,580|15,985
284,280|12,468
292,715| ||||143,700|156,565|300,265|305,183| |CREDITORS
Amounts
falling due within one year||12|(8,505)|(2,642)|(11,147)|(18,934)| |NET CURRENT|ASSETS||135,195|153,923|289,118|286,249| |TOTAL ASSETS LESS CURRENT LIABILITIES|||279,437|1,121,867|1,401,304|1,517,861| |NET ASSETS|||273,437|1,121,867|1,4D1,3D4|1.517,861| |FUNDS
Unrestricted
funds
Restricted funds||13|||279,437
1,121,867|302,461
1,215,400| |TOTALFUNDS|||||1,4D1,3D4|1,517,861| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |STAFF|COSTS|30.9.20|30.9.19| |---|---|---|---| |||E|f| |Wages|and salaries|54,459|135,917| |||54,459|135,917| ||The average
monthly
numb|er|of employees|during the year was as follows||| |---|---|---|---|---|---|---| ||Research staff||||30.9.20
2|30.9.19
=2| ||There were no employees|with emoluments||over E60,000.||| |8.|COMPARATIVES FOR THE|STATEMENT OF||FINANCIAL ACTIVITIES
Unrestricted|Restricted|Total| |||||fund|fund|funds| |||||E|f|f| ||INCOME AND ENDOWMENTS
Donations
and legacies||FROM|11,722|10,403|22,125| ||Charitable
activities
Research into and education||on oncology|10,121|119,604|129,725| ||Investment
income|||8,891|37,165
500|46,056
500| ||Otherincome|||||| ||Total|||30,734|167,672|198,406| ||EXPENDITURE ON
Raising funds|||4,051|16,986|21,037| ||Charitable
activities
Research into and education||on oncology|14,456|152,178|166,634| |||||18,507|169,164|187,671| |o the Financial Statements
-continued
Year Ended 30Se tember 2020|o the Financial Statements
-continued
Year Ended 30Se tember 2020|o the Financial Statements
-continued
Year Ended 30Se tember 2020||| |---|---|---|---|---| |COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES -continued
Unrestricted|||Restricted|Total| ||fund||fund|funds| ||E||f|E| |Net gains on investments|I3 314||13894
P|17,208| |NET INCOME|15,541||12,402|27,943| |RECONCILIATION
OF FUNDS||||| |Total funds brought forward|286,920|1,202,998||1,489,918| |TOTAL FUNDS CARRIED FORWARD|302,461|1,215,400||1,517,861| ## ## ## ## ## ## ## |Fighting
Breast Cancer|25,085|5,415|(388)|(1,964)|28,148| |---|---|---|---|---|---| ||302,461|15,593|(14931)|(23,686)|279,437| |Restricted|||||| |funds|||||| |Prof P Hoskin
Dr A Makris
Dr P Ostler|560,699
100,070
26,302|51,238
2,622
1,276|(40,813)
(3,402)
(231)|(43,907)
(7,836)
(2,060)|527,217
91,454
25,287| |Dr C Lemon
Dr M Harrison
Dr N Shah
Dr D Miles|211,478
19,742
69,299
105,742|10,778
517
1,816
2,771|(29,127)
(173)
(409)
(3,555)|(16,561)
(1,5461
(5,427)
(&,280)|176,568
18,540
65,279
96,678| |Dr 5
Mawdsley
Dr R Alonzi
Development|14,552
19,442
72,856|381
3,940
1,909|(128)
(1,310)
(890)|(1,140)
(1,522)
(5,705)|13,665
20,550
68,170| |Cyberknife
Fund|7,482|2,762|(714)|(586)|8,944| |Dr Westbury
/GuPPY
Dr Neel Bhuva|6,465
1.271|169
2,284|(57)
(11)|(506)
(100)|6,071
3,444| ||1,215,400|82,463|(80,820)|(95,176)|1,121,867| |TOTAL FUNDS|1,517,861|98,056|(95,751)|(118,862)|1,401,304| ## |The Mount Vernon Marie Curie Research|The Mount Vernon Marie Curie Research||| |---|---|---|---| |~ltli
t
t|||| |Detailed Statement of Financial Activities|||| |for the Year Ended 30Se tember 2020||30.9.20|30.9.19| |||E|E| |INCOME AND ENDOWMENTS|||| |Donations
and legacies
Donations
Legacies||17,884
1,000|20,088
2,037| |||18,884|22,125| |Investment
income
Other investment
income||40,188|46,056| |Charitable
activities
Grants||37,584|129,725| |Other income
Training
income||1,400|500| |Total incoming resources||98,056|198,406| |EXPENDITURE|||| |Investment
management|costs|13339|21037| |Portfolio management|||| |Charitable
activities
Research salaries
Research materials||54,459
1,705
90|135,917
2,554
20| |Transport expenses
Lecture fees
Conference
Computer
expenses||(110)
6,527
4,412|200
9,979
146| |||67,083|148,816| |Support costs|||| |Other
Subscriptions
Administrative
expenses
Carried forward||1,526
8,288
9,814|1,333
8,796
10,129| |Detailed Statement of Financial|Detailed Statement of Financial|Activities||| |---|---|---|---|---| |for the Year Ended 30Se|tember 2020||30.9.20|30.9.19| ||||E|E| |Other
Brought forward
Travelling
Student training|||9,814
715|10,129
1,203
1,686| ||||10,529|13,018| |Governance
costs
Auditors'
remuneration
Auditors'
remuneration|for non audit work||3,600
1,200|3,600
1,200| ||||4,800|4,800| |Total resources expended|||95,751|187,671| |Net income before gains|and losses||2,305|10,735| |Realised recognised
gains and||losses||| |Realised gains/(losses)
on fixed asset
investments|||(28,659)|23,867| |Net (expenditure)/income|||(26,354)|34,602|